- Messages
- 1,594
- Type of diabetes
- Family member
- Treatment type
- I do not have diabetes
Clinical Trial Examining the Barriers and Benefits of Exercise in Type 1 Diabetes: EXTOD
The aim of this study is to find out if exercise preserves and protects the insulin producing pancreatic beta cells in people with Type 1 diabetes.
This study is a multi-centre study around England and is open to those who have been diagnosed with type 1 diabetes in the past 8 weeks.
To take part, you must:
● Be aged between 16 and 60 years
● Have been diagnosed with Type 1 diabetes within the previous 8 weeks
● Feel able to increase your current levels of exercise
● Be willing to self-monitor and record blood glucose levels
● Be willing to take insulin as part of a multiple dose injection regime (i.e. 4 or more insulin injections per day)
Details about the clinical trial
You will be placed at ‘random’ in one of two groups: One group will be asked to have ‘usual diabetes care’.
The other will be asked to undertake more ‘exercise’, and supported to do this. This group will be helped through provision of membership to leisure centres, gyms or swimming pools. They will also be provided advice and guidance to ensure that this exercise does not result in hypoglycaemia (low blood sugar), as well as motivational contact from diabetes nurses and dieticians.
This ‘exercise’ group will be asked to maintain this level of exercise for 1 year.
Both groups will have blood tests taken at 0, 3, 6, 9 months, and after a year. Urine tests and tests of fitness levels (on an exercise cycle) at 0 and 6 months, as well as after a year. This study will finish after this one year.
Benefits include
● Your contribution to diabetes research
● Free membership to gyms and fitness facilities
● Weight loss
● Access to diabetes specialists including dieticians and diabetes nurses
● Ongoing motivational support, advice and guidance
● Support with insulin and carbohydrate adjustment
● Reimbursement of transport costs
The aim of this study is to find out if exercise preserves and protects the insulin producing pancreatic beta cells in people with Type 1 diabetes.
This study is a multi-centre study around England and is open to those who have been diagnosed with type 1 diabetes in the past 8 weeks.
To take part, you must:
● Be aged between 16 and 60 years
● Have been diagnosed with Type 1 diabetes within the previous 8 weeks
● Feel able to increase your current levels of exercise
● Be willing to self-monitor and record blood glucose levels
● Be willing to take insulin as part of a multiple dose injection regime (i.e. 4 or more insulin injections per day)
Details about the clinical trial
You will be placed at ‘random’ in one of two groups: One group will be asked to have ‘usual diabetes care’.
The other will be asked to undertake more ‘exercise’, and supported to do this. This group will be helped through provision of membership to leisure centres, gyms or swimming pools. They will also be provided advice and guidance to ensure that this exercise does not result in hypoglycaemia (low blood sugar), as well as motivational contact from diabetes nurses and dieticians.
This ‘exercise’ group will be asked to maintain this level of exercise for 1 year.
Both groups will have blood tests taken at 0, 3, 6, 9 months, and after a year. Urine tests and tests of fitness levels (on an exercise cycle) at 0 and 6 months, as well as after a year. This study will finish after this one year.
Benefits include
● Your contribution to diabetes research
● Free membership to gyms and fitness facilities
● Weight loss
● Access to diabetes specialists including dieticians and diabetes nurses
● Ongoing motivational support, advice and guidance
● Support with insulin and carbohydrate adjustment
● Reimbursement of transport costs
